4D Molecular Therapeutics, Inc. Files Important SEC Form – Issuer Identified as Company Number 0001650648
In a recent SEC filing, 4D Molecular Therapeutics, Inc. (Issuer) submitted Form 4 disclosing changes in ownership of company insiders....
In a recent SEC filing, 4D Molecular Therapeutics, Inc. (Issuer) submitted Form 4 disclosing changes in ownership of company insiders....
In a recent SEC filing, Bizily Scott (CIK: 0001920738) disclosed important information that sheds light on the company's financial standing...
Socket Mobile, Inc. has filed a Form 4 with the Securities and Exchange Commission, indicating a significant event involving the...
In a recent SEC filing, Mills Kevin J (CIK: 0001192160) reported a significant transaction that has caught the attention of...
In a recent SEC filing, Goodman Corey S (CIK: 0001278411) reported a significant transaction that has caught the attention of...
In a recent SEC filing, Adelman Robert J (0001329161) has reported a transaction that has caught the attention of investors...
In a recent SEC filing, venBio Global Strategic Fund III, L.P. (CIK: 0001739920) disclosed important information that investors and stakeholders...
Artiva Biotherapeutics, Inc. recently filed a Form 3 with the Securities and Exchange Commission (SEC), indicating significant changes in the...
In a recent SEC filing, VENBIO GLOBAL STRATEGIC GP III, LTD (0001869300) disclosed important information that investors and stakeholders should...
In a recent SEC filing, VENBIO GLOBAL STRATEGIC GP III, L.P. (CIK: 0001869303) reported important information that could impact its...
In a recent SEC filing, RA Capital Healthcare Fund LP (0001315082) reported its latest activity, signaling potential changes within the...
In a recent Securities and Exchange Commission (SEC) filing, RA Capital Management, L.P. (CIK: 0001346824) reported its latest activities, shedding...